Common use of Certain Notifications and Required Actions Clause in Contracts

Certain Notifications and Required Actions. After the date of this Agreement, the Company shall promptly advise the Representative in writing of: (i) the receipt of any comments of, or requests for additional or supplemental information from, the Commission; (ii) the time and date of any filing of any post-effective amendment to the Registration Statement or any amendment or supplement to any preliminary prospectus, the Time of Sale Prospectus, any free writing prospectus or the Prospectus;

Appears in 1 contract

Sources: Underwriting Agreement (Global Ship Lease, Inc.)

Certain Notifications and Required Actions. After the date of this Agreement, the Company shall promptly advise the Representative in writing of: (i) of the receipt of any comments of, or requests for additional or supplemental information from, the Commission; , to the extent such comments or requests are related to the offering and sale of the Offered Shares, (ii) of the time and date of any filing of any post-effective amendment to the Registration Statement or any amendment or supplement to any preliminary prospectus, the Time of Sale Prospectus, any free writing prospectus or the Prospectus;, (iii) of the time and date that any post-effective amendment

Appears in 1 contract

Sources: Underwriting Agreement (Cti Biopharma Corp)

Certain Notifications and Required Actions. After the date of this Agreement, the Company shall promptly advise the Representative Representatives in writing of: (i) the receipt of any comments of, or requests for additional or supplemental information from, the Commission; (ii) the time and date of any filing of any post-effective amendment to the Registration Statement or any amendment or supplement to any preliminary prospectus, the Time of Sale Prospectus, any free writing prospectus or the Prospectus;; (iii) the time and date that any post-effective amendment to the Registration Statement becomes effective; and

Appears in 1 contract

Sources: Underwriting Agreement (Kite Pharma, Inc.)